Cargando…

Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables

INTRODUCTION: Today cocaine use is very frequently associated with adolescents with maladaptive personality traits and impulse control disorder. It requires a multidisciplinary approach and individualized treatments to improve the clinic and achieve the abandonment of consumption. OBJECTIVES: 1. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez, S. Pérez, Herrero, I. Martín, Fernández, M.A. Cutillas, Güimil, D. Raya, Portero, A. Crespo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528295/
http://dx.doi.org/10.1192/j.eurpsy.2021.618
_version_ 1784801273557549056
author Sánchez, S. Pérez
Herrero, I. Martín
Fernández, M.A. Cutillas
Güimil, D. Raya
Portero, A. Crespo
author_facet Sánchez, S. Pérez
Herrero, I. Martín
Fernández, M.A. Cutillas
Güimil, D. Raya
Portero, A. Crespo
author_sort Sánchez, S. Pérez
collection PubMed
description INTRODUCTION: Today cocaine use is very frequently associated with adolescents with maladaptive personality traits and impulse control disorder. It requires a multidisciplinary approach and individualized treatments to improve the clinic and achieve the abandonment of consumption. OBJECTIVES: 1. To assess the efficacy of monthly injectable paliperidone palmitate treatment in controlling impulsivity. 2. Determine the consumption of toxins after treatment. METHODS: Sample: Adolescents, 14-17 years old, with a diagnosis of Personality Limit T and cocaine consumption who start treatment with Paliperidone Palmitate LD IM (50-100mg / month) in monotherapy, with Diazepam 5mg if significant anxiety. Retrospective data collection. Plutchik impulsivity scale (IE) before starting treatment and at 3 months. Statistical analysis SPSS 20.0 RESULTS: Twelve adolescents who met the inclusion criteria were included and 12 adolescents, 83% male, 16% female, completed the questionnaires. After its application and correction through non-parametric tests (N <30), scores in the EI questionnaire of a mean of 37.42 points in the pretest were observed, corresponding to a severe level of impulsivity; and a mean of 26.28 points in the post-test, compatible with a mild-moderate degree of impulsive symptoms. A decrease in the consumption of toxins was observed in 65% of the cases. CONCLUSIONS: In our experience, the management of toxic consumption in adolescent population with severe impulsivity symptoms has great limitations due to the scarce resources available. The Palpitate of Paliperidone long-term treatment has been useful in the approach of serious registered cases, being associated with symptomatic improvement and decrease in consumption.
format Online
Article
Text
id pubmed-9528295
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95282952022-10-17 Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables Sánchez, S. Pérez Herrero, I. Martín Fernández, M.A. Cutillas Güimil, D. Raya Portero, A. Crespo Eur Psychiatry Abstract INTRODUCTION: Today cocaine use is very frequently associated with adolescents with maladaptive personality traits and impulse control disorder. It requires a multidisciplinary approach and individualized treatments to improve the clinic and achieve the abandonment of consumption. OBJECTIVES: 1. To assess the efficacy of monthly injectable paliperidone palmitate treatment in controlling impulsivity. 2. Determine the consumption of toxins after treatment. METHODS: Sample: Adolescents, 14-17 years old, with a diagnosis of Personality Limit T and cocaine consumption who start treatment with Paliperidone Palmitate LD IM (50-100mg / month) in monotherapy, with Diazepam 5mg if significant anxiety. Retrospective data collection. Plutchik impulsivity scale (IE) before starting treatment and at 3 months. Statistical analysis SPSS 20.0 RESULTS: Twelve adolescents who met the inclusion criteria were included and 12 adolescents, 83% male, 16% female, completed the questionnaires. After its application and correction through non-parametric tests (N <30), scores in the EI questionnaire of a mean of 37.42 points in the pretest were observed, corresponding to a severe level of impulsivity; and a mean of 26.28 points in the post-test, compatible with a mild-moderate degree of impulsive symptoms. A decrease in the consumption of toxins was observed in 65% of the cases. CONCLUSIONS: In our experience, the management of toxic consumption in adolescent population with severe impulsivity symptoms has great limitations due to the scarce resources available. The Palpitate of Paliperidone long-term treatment has been useful in the approach of serious registered cases, being associated with symptomatic improvement and decrease in consumption. Cambridge University Press 2021-08-13 /pmc/articles/PMC9528295/ http://dx.doi.org/10.1192/j.eurpsy.2021.618 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Sánchez, S. Pérez
Herrero, I. Martín
Fernández, M.A. Cutillas
Güimil, D. Raya
Portero, A. Crespo
Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables
title Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables
title_full Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables
title_fullStr Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables
title_full_unstemmed Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables
title_short Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables
title_sort adolescents and dual pathology. assessment of treatment with paliperidona palmitato long-term injectables
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528295/
http://dx.doi.org/10.1192/j.eurpsy.2021.618
work_keys_str_mv AT sanchezsperez adolescentsanddualpathologyassessmentoftreatmentwithpaliperidonapalmitatolongterminjectables
AT herreroimartin adolescentsanddualpathologyassessmentoftreatmentwithpaliperidonapalmitatolongterminjectables
AT fernandezmacutillas adolescentsanddualpathologyassessmentoftreatmentwithpaliperidonapalmitatolongterminjectables
AT guimildraya adolescentsanddualpathologyassessmentoftreatmentwithpaliperidonapalmitatolongterminjectables
AT porteroacrespo adolescentsanddualpathologyassessmentoftreatmentwithpaliperidonapalmitatolongterminjectables